e-learning
resources
Milan 2017
Wednesday, 13.09.2017
From the bench: therapeutic approaches in COPD and emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapeutic effects of human perivascular stem cells in an emphysema mouse model
S. HONG (Chuncheon, Republic of Korea)
Source:
International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Session:
From the bench: therapeutic approaches in COPD and emphysema
Session type:
Poster Discussion
Number:
4932
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. HONG (Chuncheon, Republic of Korea). Therapeutic effects of human perivascular stem cells in an emphysema mouse model. 4932
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012
Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019
The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015
Induced pluripotent stem cell derived macrophages differentiate into AM like cells in the lungs of humanized PAP mice
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Therapeutic benefits of exosomes derived from mesenchymal stromal cells in bleomycin-induced pulmonary fibrosis in aged mice.
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Adult mouse and human airway epithelial basal stem cells
Source: Eur Respir Monogr 2021; 91: 56-69
Year: 2021
In vivo models of human airway epithelium repair and regeneration
Source: Eur Respir Rev 2005; 14: 131-136
Year: 2005
In vivo
chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept